NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Rivastigmine Tartrate Capsules USP, used for the treatment of dementia disease, in the American market. "The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rivastigmine Tartrate Capsules…

news

A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C. The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in…

news

The National Pharmaceutical Pricing Authority (NPPA) is thinking of taking a crack at settling disputes with drug makers such as Cipla over penalties for allegedly charging too much for medicines. According to data from India's drug pricing watchdog, outstanding dues on this count from scores of companies exceed Rs 4,551…

news

The pharmaceutical industry has expressed concern about negotiating a new deal on drug costs with a caretaker government. Talks between the Department of Health, the Department of Public Expenditure and Reform and representatives of the research-based pharmaceutical companies in Ireland are due to commence today. Minister for Health Leo Varadkar…

news

Ahmedabad-based Rs 4,700-crore pharma major, Torrent Pharmaceuticals, has sought approvals from its shareholders to raise Rs 10,500 crore through issue of shares and other securities to fund its growth activity. The company said it was prudent to have approvals in place as it would help the harmaceutical major to take…

news

AstraZeneca's heart drug Brilinta has failed to help stroke patients as hoped in a big clinical trial, dealing a blow to the company's expectations that the medicine could rack up annual sales of $3.5 billion by 2023. The trial found the blood-thinner was not significantly better than aspirin, the current…

news

India's largest drug maker Sun Pharma has teamed up with multinational drug giant AstraZeneca to promote and distribute the latest generation anti-diabetes drug dapagliflozin under the brand name Oxra. Sun's alliance with AstraZeneca will add to its portfolio of existence innovative anti-diabetes products like Istavel and Istamet, which it markets…

news

India's drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has moved in to back the health ministry in its efforts to check "irrational" fixed dose combinations (FDCs) -- it will review afresh all new applications for price fixations of FDC and examine their safety and efficacy. The regulator has also…

news

Quest Pharmatech Inc Says subsidiary, Oncoquest Inc. has signed an agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. Oncoquest will license Greater China rights to immunotherapy technologies and provide 1 million usd for 46% of shares of oncovent. Agreement results in creation of a new company in china called Oncovent Co.,…

news

A new cystic fibrosis treatment from Vertex Pharmaceuticals has been rejected as too expensive by Britain's healthcare cost agency NICE. The National Institute for Health and Care Excellence (NICE) said on Wednesday that Orkambi, priced at an annual 104,000 pounds ($149,000) per patient, was not a cost-effective use of state…